Abbott's Medical Devices segment, especially CGM, continues to deliver robust double-digit growth, offsetting Nutrition ...

Abbott Laboratories' (NYSE: ABT) January 2026 price pullback is making its stock look attractively valued. The move, driven ...

Two owners of Abby’s Bakery in Los Fresnos, Texas, have been sentenced to prison after a federal jury found them guilty of ...

Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...

Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22, as the market digested weaknesses from its fourth-quarter and full-year earnings report. | Abbott Laboratories saw ...

Abbott Laboratories reported fourth quarter sales below expectations before the market opened on Jan. 22, sending the stock down nearly 12% from the prior day's closing. The biggest hits came from ...

Abbott reports fourth-quarter sales that miss analysts’ estimates.

Cuellar is the brother of U.S. Rep. Henry Cuellar, D-Laredo, who was recently pardoned on federal corruption charges by ...

Greenland is only mentioned twice in the famous publication entitled Project 2025. Presidential Transition Project aka ...

US stocks climb as tensions ease, but markets stay cautious ahead of key PCE inflation data and major earnings updates.

Along with decreased headwinds, Abbott's diagnostics business is expected to get a boost with its $23 billion acquisition of Exact Sciences, which is anticipated to close in the second quarter.

Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the ...